Clinical Trials Sponsored by Shenzhen Institutes of Advanced Technology Chinese Academy of Science

Total 806 results

Cancer Institute and Hospital, Chinese Academy...

Unknown

Online Noninvasive Assessment of Human Brain Death and Deep Coma by Near-infrared Spectroscopy

Brain Death | Coma

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

PCI for Patients With ES-SCLC After RCT:a Prospective Randomized Study

Small-cell Lung Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

Radiotherapy Combined With GDP With or Without Chidamide in Stage I/II Extranodal Nasal NK/T-cell Lymphoma

Lymphoma

China
Cancer Institute and Hospital, Chinese Academy...

Completed

The Value of Concurrent Chemoradiotherapy for Stage II Nasopharyngeal Carcinoma

Nasopharyngeal Carcinoma

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

Toripalimab Combine With Rituximab for Treatment of Relapsed Refractory CD20 Positive Diffuse Large B-cell Lymphoma

Diffuse Large B-cell Lymphoma | Rituximab | Toripalimab

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

Taxane Induced Peripheral Neuropathy in Chinese Patients With Breast Cancer

Breast Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Completed

Randomized Trial of Accelerated Partial Breast Irradiation

Breast Neoplasms | Neoplasm Recurrence, Local

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

Real-world Treatment Patterns and Clinical Outcomes in EGFR-mutant Unresectable Locally Advanced NSCLC

Non Small Cell Lung Cancer | Stage III Non-small-cell Lung Cancer | EGFR Mutation-Related Tumors
Cancer Institute and Hospital, Chinese Academy...

Completed

Tomotherapy for Leptomeningeal Metastases

Leptomeningeal Metastasis

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

Pyrotinib Plus Fulvestrant in Patients With HR+/HER2+ Metastatic Breast Cancer (Pyrotinib+Fulvestrant ) (Pyrotinib)

Breast Cancer | HER2-positive Breast Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

Study of Apatinib Combined With Oral Vinorelbine in Metastatic HER2 Negative Breast Cancer

Breast Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

Radiotherapy With or Without Concurrent Chemotherapy for Extensive Lymphatic Metastasis of Esophageal Cancer - 3JECROG P-03

IMRT With or Without Concurrent Chemotherapy for Esophageal Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Completed

A Phase Ⅲ Randomized Clinical Trial of Postmastectomy Hypofractionation Radiotherapy in High-risk Breast Cancer

Breast Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

Safety and Efficacy of Anlotinib in Combination With Irinotecan in Patients With Pretreated Advanced Colorectal Cancer

Colo-rectal Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

Study of Hypo-fractionated Neoadjuvant Radiotherapy for Locally Advanced Gastric Cancer

Gastric Cancer | Chemoradiation

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

Perioperative Electroacupuncture After Operation

Acupuncture | Gastrointestinal Function

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

Study of Apatinib as Third-line and Later Therapy in Patients With Small Cell Lung Cancer (SCLC)

Small Cell Lung Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Completed

Study of Postoperative 3D-CRT/IMRT in Hepatocellular Carcinoma

Hepatocellular Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

Tomotherapy for Refractory Brain Metastases (TRBM)

Brain Metastases

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

IORT Versus CCRT for Pancreatic Cancer (IVCPC)

Pancreatic Cancer Stage IV

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

Icotinib in Non-small Cell Lung Cancer Patients With Uncommon EGFR Mutation

Non-small Cell Lung Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

The Effect of Zhen Qi Shen Capsule Combined With Yu Yi Kang on Breast Cancer and Lung Cancer Patients With Chemotherapy

Breast Cancer | Lung Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Completed

Observational Study on the Patients With Rectal Cancer

Rectal Cancer | Surgery | Adjuvant Chemotherapy | Neoadjuvant Chemoradiotherapy | Adjuvant Chemoradiotherapy

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

A Randomized Phase III Study of Adjuvant Chemotherapy With or Without Chemo-radiotherapy in Patients With Local Advanced Gastric Cancer After D2 Resection.

Gastric Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

Postoperative IMRT Combined With Capecitabine for Advanced Gastric Cancer Patients

Gastric Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Completed

The Efficacy of Oxaliplatin Plus S-1 for Treatment of Gastric Cancer

Stomach Neoplasms

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

Study of Optimizing Neoadjuvant Regimens in Subtypes of Breast Cancer

Breast Cancer | Neoadjuvant Chemotherapy

China
Cancer Institute and Hospital, Chinese Academy...

Completed

Endoscopic Screening on Esophageal Cancer

Esophageal Squamous Cell Carcinoma

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

Endoscopic Ultrasound Predict the Sensitivity of Stage II / III Rectal Cancer Preoperative Concurrent Chemoradiotherapy

Rectal Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

Phase II Study of Preoperative IMRT Combined With Capecitabine and Bevacizumab in Locally Advanced Rectal Cancer

Locally Advanced Malignant Neoplasm

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

Cisplatin,Docetaxel and S-1 for Advanced Gastric and Gastroesophageal Junction Cancer

Gastric Cancer | Gastroesophageal Junction Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

Study of Bevacizumab Plus Chemotherapy in Patients With Metastatic Colorectal Cancer

Colorectal Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

Cisplatin/Etoposide and Concurrent Radiotherapy With or Without Celecoxib in Patients With Unresectable Locally Advanced Non-small Cell Lung Cancer (NSCLC)

Lung Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

The Trial Comparing Dose-dense AC-T With PC as Adjuvant Therapy for TNBC

Breast Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

Comparison Study of Neoadjuvant Paclitaxel Plus Carboplatin/Epirubicin Treatment in Triple-negative Breast Cancer

Triple Negative Breast Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

Human Papillomavirus Infection and Knowledge and Attitudes About HPV Vaccines Among Men Who Have Sex With Men (MSM)

HIV Infection | HPV Infection | Syphilis

China
Cancer Institute and Hospital, Chinese Academy...

Unknown

Primary and Secondary Prevention of Human Papillomavirus (HPV) Disease in China

Cervical Cancer | HPV Infections | Precancerous Disease of the Cervix | HPV Related Diseases
Cancer Institute and Hospital, Chinese Academy...

Not yet recruiting

A Multicentre Prospective Cohort Study: Intensive Adjuvant Therapy for TNBC With BRCA Gene Mutation

Early-stage Triple-negative Breast Cancer With BRCA1/2 Mutations

China
Cancer Institute and Hospital, Chinese Academy...

Recruiting

NALIRI-XELOX+AK104 for First-line Treatment of Advanced PDAC

Pancreatic Adenocarcinoma | Advanced Cancer | Drug Use | Capecitabine | Oxaliplatin | First-Line | Cadonilimab | Nanoliposomal Irinotecan

China
Cancer Institute and Hospital, Chinese Academy...

Not yet recruiting

A Multicentre Prospective Cohort Study: Effect of (Neo)Adjuvant Therapy on Lipids in Young Breast Cancer Patients

Lipids | Young Breast Cancer Patient | Anti-tumour Drug Therapy
Cancer Institute and Hospital, Chinese Academy...

Not yet recruiting

Clinical Trial for Advanced or Metastatic Pancreatic Cancer

Pancreas Cancer
Cancer Institute and Hospital, Chinese Academy...

Not yet recruiting

Trastuzumab Deruxtecan (T-DXd) With Pyrotinib in First-line HER2-positive Unresectable or Metastatic Breast Cancer Trial

Breast Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Phase II Study of Moderate-dose Hypofractionated RT Combined With Tislelizumab for HCC With Diffuse Tumor Thrombosis

Hepatocellular Carcinoma | Radiotherapy | Tislelizumab | Tumor Thrombosis

China
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Irinotecan, TAS-102 Plus Bevacizumab as a Second-Line Therapy in mCRC Patients

Metastatic Colorectal Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Not yet recruiting

RC48 Combined With EGFR or HER2 TKI for Locally Advanced or Metastatic NSCLC Patients With HER2 Alterations

Non Small Cell Lung Cancer | ERBB2 Mutation-Related Tumors | Disitamab Vedotin | ERBB2 Gene Duplication
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Advanced First-line Treatment of Short-term Postoperative Progression of Head and Neck Squamous Cell Carcinoma

Head and Neck Squamous Cell Carcinoma

China
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Postoperative CCRT Followed by Immunotherapy in High-Risk LA HNSCC

Head and Neck Squamous Cell Carcinoma

China
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Surgical Treatment and Molecular Marker Exploration of Locally Recurrent Colorectal Cancer

Locally Recurrent Colorectal Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Chidamide/Everolimus for PIK3CA Wild-type/Mutant HR+/HER2- Advanced Breast Cancer

Targeted Therapy | HR+/HER2- Advanced Breast Cancer

China
Cancer Institute and Hospital, Chinese Academy...

Recruiting

LK101 Combined With PD-1 or PD-L1 Monoclonal Antibody in the Treatment of Lung Cancer

Advanced Lung Carcinoma

China

Clinical Trials Sponsored by Shenzhen Institutes of Advanced Technology Chinese Academy of Science

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in China

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations